CCR2 and familial pancreatic carcinoma: It has been demonstrated that CCL2 and its receptor CCR2 are implicated in the development and progression of various malignancies, such as prostate cancer,108 breast cancer,109 hepatocellular cancer,110 lung cancer,111 renal cancer,112 pancreatic cancer,113 and nasopharyngeal carcinoma.114